Company / Capital Expenditures
IMMUCELL CORP /DE/ Capital Expenditures History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$465.7K
FY2025
5-year range
$465.7K / $4.0M
FY2021-FY2025
Trend
-75.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $4M to $465,725 over the past 2 years.
Based on SEC 10-K filings.
$465,725 in FY2025 with a 10-year CAGR of -2.5%.
Declined from $4M to $465,725 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -2.5%
Key checks
Key Insights
- In FY2025, capital expenditures decreased 75.4% year-over-year.
- Peak capital expenditures was recorded in FY2023.
- Lowest capital expenditures in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $465.7K | -75.4% |
| FY2024 | $1.9M | -52.4% |
| FY2023 | $4.0M | +10.8% |
| FY2017 | $3.6M | +31.9% |
| FY2016 | $2.7M | +354.9% |
| FY2015 | $597.7K | +117.0% |
| FY2014 | $275.4K | +13.0% |
| FY2013 | $243.7K | +109.1% |
| FY2012 | $116.5K | -74.6% |
| FY2011 | $459.5K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026